1. Acylprolinamides: A new class of peptide deformylase inhibitors with in vivo antibacterial activity
- Author
-
Glenn S. Van Aller, Swarupa G. Kulkarni, Paris Ward, Timothy Francis Gallagher, Jesus R. Medina, Celine Duquenne, Theresa Pinckney, Nino Campobasso, William H. Miller, Charles W. Blackledge, Tony W. Peng, Thomas Lewandowski, Mark A. Bobko, Jeffrey M. Axten, Seth W. Grant, and Rimma Zonis
- Subjects
Models, Molecular ,Proline ,medicine.drug_class ,Clinical Biochemistry ,Antibiotics ,Administration, Oral ,Pharmaceutical Science ,Microbial Sensitivity Tests ,Pharmacology ,Crystallography, X-Ray ,Biochemistry ,Amidohydrolases ,Structure-Activity Relationship ,Peptide deformylase ,Broad spectrum ,Bacterial Proteins ,Pharmacokinetics ,In vivo ,Drug Discovery ,medicine ,Animals ,Humans ,Potency ,Respiratory Tract Infections ,Molecular Biology ,Chemistry ,Organic Chemistry ,Amides ,Haemophilus influenzae ,Anti-Bacterial Agents ,Rats ,Disease Models, Animal ,Streptococcus pneumoniae ,Injections, Intravenous ,Molecular Medicine ,Antibacterial activity - Abstract
A new class of PDF inhibitor with potent, broad spectrum antibacterial activity is described. Optimization of blood stability and potency provided compounds with improved pharmacokinetics that were suitable for in vivo experiments. Compound 5c, which has robust antibacterial activity, demonstrated efficacy in two respiratory tract infection models.
- Published
- 2012
- Full Text
- View/download PDF